Luxiq and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Luxiq (betamethasone valerate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ambien, and have Psoriasis.

The phase IV clinical study analyzes which people have Dizziness when taking Luxiq. It is created by eHealthMe based on reports of 270 people who have side effects when taking Luxiq from the FDA, and is updated regularly.

What is Luxiq?

Luxiq has active ingredients of betamethasone valerate. eHealthMe is studying from 272 Luxiq users. Check the latest studies of Luxiq.

What is Dizziness?

Dizziness is found to be associated with 3,566 drugs and 5,710 conditions by eHealthMe. Check the latest studies of Dizziness.

On Jul, 14, 2026

270 people reported to have side effects when taking Luxiq.
Among them, 11 people (4.07%) have Dizziness.

Among these 11 people:

How long have people been on Luxiq when they have Dizziness? *

What is the gender of people who have Dizziness when taking Luxiq? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Dizziness when taking Luxiq? *

What are other drugs people take besides Luxiq? *

What are other side effects people have besides Dizziness? *

Weakness: 7 people, 63.64%
Dyspnea (difficult or laboured breathing): 7 people, 63.64%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 6 people, 54.55%
Joint Pain: 6 people, 54.55%
Pain: 6 people, 54.55%
Abdominal Pain: 5 people, 45.45%
Nausea (feeling of having an urge to vomit): 5 people, 45.45%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 45.45%
Rash Erythematous (redness of the skin): 5 people, 45.45%
Hypotension (abnormally low blood pressure): 5 people, 45.45%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 27.27%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 27.27%
Heart Rate Irregular: 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 1 person, 9.09%
Leukaemia (blood or bone marrow cancer): 1 person, 9.09%
Iron Overload: 1 person, 9.09%
Iron Metabolism Disorder: 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Luxiq and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Luxiq:

Luxiq (272 reports)

Dizziness treatments and more:

Dizziness (613,960 reports)

Browse all side effects of Luxiq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,566 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,710 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone valerate (the active ingredients of Luxiq) and Luxiq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.